We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$2.52B
AUM Growth
-$173M
(-6.4%)
Cap. Flow
-$49.2M
Cap. Flow
% of AUM
-1.95%
Top 10 Holdings %
Top 10 Hldgs %
37.25%
Holding
3,473
New
218
Increased
908
Reduced
1,467
Closed
292
Avg Time Held Equity + Options
3
years
Top 10 Avg Time Held Equity + Options
2.4
years
Top 20 Avg Time Held Equity + Options
2.4
years
Avg Time Held Equity only
3
years
Top 10 Avg Time Held Equity only
2.4
years
Top 20 Avg Time Held Equity only
2.4
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Fallen Angels USD Bond ETF
FALN
|
+$9.31M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$6.87M |
| 3 |
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
|
+$3.6M |
| 4 |
Corcept Therapeutics
CORT
|
+$3M |
| 5 |
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
|
+$2.68M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard ESG US Stock ETF
ESGV
|
+$9.63M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$7.01M |
| 3 |
Microsoft
MSFT
|
+$5.41M |
| 4 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$5.16M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$4.44M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 51.1% |
| 2 | Technology | 15.39% |
| 3 | Financials | 8.2% |
| 4 | Healthcare | 7.16% |
| 5 | Consumer Discretionary | 5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3201
Children's Place
PLCE
$25.4M
| $0 | ﹤0.01% |
6
| – | – |
2016 Q4
21 quarters
|
|
3202
Palomar
PLMR
$3.65B
| – | – |
-1,275
| Closed | -$83K | – |
|
3203
Douglas Dynamics
PLOW
$913M
| – | – |
-11
| Closed | -$400 | – |
|
3204
Playtika
PLTK
$835M
| $0 | ﹤0.01% |
6
-341
| -98% | -$6.07K |
2021 Q4
1 quarter
|
|
3205
ePlus
PLUS
$2.48B
| $0 | ﹤0.01% |
6
-24
| -80% | -$1.19K |
2020 Q4
5 quarters
|
|
3206
DELISTED
Playa Hotels & Resorts
PLYA
| – | – |
-56
| Closed | – | – |
|
3207
PMV Pharmaceuticals
PMVP
$69.5M
| – | – |
-23
| Closed | -$1K | – |
|
3208
Pennant Group
PNTG
$1.47B
| – | – |
-13
| Closed | – | – |
|
3209
Praxis Precision Medicines
PRAX
$6.92B
| – | – |
-5
| Closed | -$1K | – |
|
3210
Profound Medical
PROF
$235M
| $0 | ﹤0.01% |
+30
| New | +$289 |
2022 Q1
0 quarters
|
|
3211
ProQR Therapeutics
PRQR
$207M
| – | – |
-770
| Closed | -$6K | – |
|
3212
ProPetro Holding
PUMP
$967M
| $0 | ﹤0.01% |
4
-1,949
| -100% | -$23.3K |
2021 Q3
2 quarters
|
|
3213
Invesco National AMT-Free Municipal Bond ETF
PZA
$4.08B
| – | – |
-2,908
| Closed | -$79K | – |
|
3214
High Templar Tech Ltd
HTT
$328M
| – | – |
-1,058
| Closed | -$1K | – |
|
3215
uniQure
QURE
$1.51B
| $0 | ﹤0.01% |
+6
| New | +$105 |
2022 Q1
0 quarters
|
|
3216
Ribbon Communications
RBBN
$243M
| – | – |
-562
| Closed | -$3K | – |
|
3217
Avita Medical
RCEL
$409M
| $0 | ﹤0.01% |
40
| – | – |
2021 Q1
4 quarters
|
|
3218
Riley Exploration Permian
REPX
$1.04B
| – | – |
-13
| Closed | – | – |
|
3219
RPC Inc
RES
$1.31B
| – | – |
-847
| Closed | -$4K | – |
|
3220
Rafael Holdings
RFL
$78M
| – | – |
-42
| Closed | – | – |
|
3221
Regis Corp
RGS
$72.2M
| $0 | ﹤0.01% |
3
| – | – |
2021 Q1
4 quarters
|
|
3222
Rigetti Computing
RGTI
$4.05B
| $0 | ﹤0.01% |
30
| – | – |
2021 Q4
1 quarter
|
|
3223
Ryman Hospitality Properties
RHP
$8.74B
| $0 | ﹤0.01% |
3
+1
| +50% | +$89 |
2021 Q4
1 quarter
|
|
3224
Rocket Companies
RKT
$31.3B
| – | – |
-20
| Closed | – | – |
|
3225
Relay Therapeutics
RLAY
$3.83B
| – | – |
-71
| Closed | -$2K | – |
|
Similar funds
Parallel Advisors's Q1 2022 Portfolio in Review
As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Parallel Advisors's Q1 2022 filing shows 218 new, 908 increased, 1,467 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.
By sector, the portfolio is most concentrated in Miscellaneous at 51% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
- Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
- Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
- Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
- Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
- Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
- Parallel Advisors opened 218 new positions and closed 292 in Q1 2022.
- Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.
Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.